Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00409

Submission Number:
00409
Commenter:
Neal Dungan
State:
New Mexico
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Vertical integration of PBM's and Pharmacy Networks will limit access and ultimately drive up prescription costs. Lack of transparency in the prescription delivery system does not allow proper vetting of the assertion that this will result in savings to the patient. It will, however, certainly limit access to patient healthcare. Drugs without proper information is NOT the answer to proper healthcare. Limiting patient choices will be the outcome of allowing these contrivances to control the system AND the cost will go up. Neal Dungan see attachment